A detailed history of Headinvest, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Headinvest, LLC holds 27,872 shares of PFE stock, worth $772,054. This represents 0.17% of its overall portfolio holdings.

Number of Shares
27,872
Previous 31,839 12.46%
Holding current value
$772,054
Previous $1.06 Million 24.05%
% of portfolio
0.17%
Previous 0.23%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024

SELL
$26.13 - $33.94 $103,657 - $134,639
-3,967 Reduced 12.46%
27,872 $802,000
Q3 2023

Dec 11, 2023

SELL
$32.09 - $37.51 $13,670 - $15,979
-426 Reduced 1.32%
31,839 $1.06 Million
Q2 2023

Aug 23, 2023

BUY
$36.12 - $41.79 $39,370 - $45,551
1,090 Added 3.5%
32,265 $1.18 Million
Q1 2023

May 17, 2023

SELL
$39.39 - $51.28 $558,274 - $726,791
-14,173 Reduced 31.25%
31,175 $1.27 Million
Q4 2022

Feb 13, 2023

SELL
$41.75 - $54.5 $31,354 - $40,929
-751 Reduced 1.63%
45,348 $2.32 Million
Q3 2022

Dec 28, 2022

BUY
$43.76 - $53.42 $45,948 - $56,091
1,050 Added 2.33%
46,099 $2.02 Million
Q2 2022

Aug 12, 2022

BUY
$46.53 - $55.17 $23,776 - $28,191
511 Added 1.15%
45,049 $2.36 Million
Q1 2022

May 13, 2022

BUY
$45.75 - $56.69 $12,855 - $15,929
281 Added 0.63%
44,538 $2.31 Million
Q4 2021

Feb 11, 2022

BUY
$41.32 - $61.25 $1,033 - $1,531
25 Added 0.06%
44,257 $2.61 Million
Q3 2021

Nov 16, 2021

SELL
$39.25 - $50.42 $235 - $302
-6 Reduced 0.01%
44,232 $1.9 Million
Q2 2021

Aug 30, 2021

SELL
$35.91 - $40.68 $20,648 - $23,391
-575 Reduced 1.28%
44,238 $1.73 Million
Q1 2021

May 13, 2021

BUY
$33.49 - $37.77 $104,388 - $117,729
3,117 Added 7.48%
44,813 $1.62 Million
Q4 2020

Feb 16, 2021

BUY
$33.47 - $42.56 $85,047 - $108,144
2,541 Added 6.09%
44,237 $1.63 Million
Q4 2020

Feb 16, 2021

SELL
$33.47 - $42.56 $85,047 - $108,144
-2,541 Reduced 5.74%
41,696 $1.53 Million
Q3 2020

Nov 24, 2020

BUY
$31.75 - $37.25 $100,171 - $117,523
3,155 Added 8.19%
41,696 $1.53 Million
Q2 2020

Aug 12, 2020

BUY
$30.12 - $36.54 $183,129 - $222,163
6,080 Added 18.73%
38,541 $1.26 Million
Q1 2020

May 12, 2020

BUY
$27.03 - $38.62 $67,602 - $96,588
2,501 Added 8.35%
32,461 $1.06 Million
Q1 2020

May 11, 2020

SELL
$27.03 - $38.62 $35,111 - $50,167
-1,299 Reduced 4.16%
29,960 $927,000
Q4 2019

Feb 14, 2020

BUY
$32.92 - $37.36 $19,093 - $21,668
580 Added 1.89%
31,259 $1.23 Million
Q3 2019

Nov 21, 2019

BUY
$32.49 - $42.13 $3,866 - $5,013
119 Added 0.39%
30,679 $1.1 Million
Q2 2019

Aug 22, 2019

BUY
$36.98 - $41.52 $22,187 - $24,912
600 Added 2.0%
30,560 $1.32 Million
Q1 2019

May 15, 2019

SELL
$37.5 - $41.2 $1.12 Million - $1.23 Million
-29,960 Reduced 50.0%
29,960 $1.27 Million
Q4 2018

Feb 22, 2019

BUY
$38.47 - $43.86 $1.15 Million - $1.31 Million
29,860 Added 99.33%
59,920 $2.62 Million
Q3 2018

Nov 14, 2018

BUY
$34.47 - $41.81 $1,895 - $2,299
55 Added 0.18%
30,060 $1.33 Million
Q2 2018

Aug 09, 2018

SELL
$32.98 - $35.16 $4,155 - $4,430
-126 Reduced 0.42%
30,005 $1.09 Million
Q1 2018

Apr 09, 2018

SELL
$31.91 - $37.02 $4,786 - $5,553
-150 Reduced 0.5%
30,131 $1.07 Million
Q3 2017

Nov 13, 2017

BUY
$31.0 - $34.15 $938,711 - $1.03 Million
30,281
30,281 $1.06 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $155B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Headinvest, LLC Portfolio

Follow Headinvest, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Headinvest, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Headinvest, LLC with notifications on news.